# Internal Review — Claude Code (Round 1)

**Reviewer:** Claude Code (Internal)
**Paper:** Back to Work? Early Termination of Pandemic Unemployment Benefits and Medicaid Home Care Provider Supply
**Date:** 2026-03-02

---

## PART 1: CRITICAL REVIEW

### 1. Identification and Empirical Design

The identification strategy is strong. The paper exploits staggered voluntary termination of the $300/week FPUC supplement across 26 states using the Callaway-Sant'Anna (2021) heterogeneity-robust estimator. Treatment cohorts are well-defined (22 states in July 2021, 4 in August 2021), with 25 never-treated jurisdictions as the comparison group and 41 months of pre-treatment data.

**Strengths:**
- CS-DiD is the appropriate estimator for this setting (staggered adoption with heterogeneous timing)
- Behavioral health placebo is well-motivated: uses the same administrative data, same states, same time periods, different wage level
- Bacon decomposition confirms 99.4% of TWFE weight is treated-vs-untreated, mitigating bias concerns
- Within-region analysis (South, Midwest) addresses geographic confounders

**Concerns:**
- The 26 treated states share political characteristics (Republican governors). While the paper discusses this, the behavioral health placebo is the main defense. The placebo is convincing but operates through a different mechanism channel (wage level), not through political economy channels.
- Placebo timing test shifts treatment 2 years (to 2019). Could also show placebo at 1 year (2020), though the COVID disruption complicates interpretation.

### 2. Inference and Statistical Validity

Statistical inference is appropriate:
- CS-DiD with multiplier bootstrap (1,000 iterations) for confidence intervals
- State-clustered standard errors for TWFE specifications
- Randomization inference: CS-DiD RI (200 permutations, p=0.040) and TWFE RI (500 permutations, p=0.156)
- The CS-DiD RI is particularly valuable as it validates the preferred specification

**Minor concern:** The TWFE RI p-value (0.156) is notably different from the CS-DiD RI p-value (0.040). The paper acknowledges this difference but could discuss why the estimators diverge more here — likely reflecting heterogeneous treatment effects across cohorts that TWFE pools inappropriately.

### 3. Robustness and Alternative Explanations

The robustness battery is comprehensive:
- Bacon decomposition, within-region (South/Midwest), placebo timing (2019), outlier exclusion (NY/CA)
- Dual randomization inference (CS-DiD and TWFE)
- Triple-difference (HCBS vs BH)
- Intensive margin (claims/provider, beneficiaries/provider)

No major gaps. The paper honestly reports that the triple-diff is imprecise (p=0.14), which is appropriate.

### 4. Contribution and Literature Positioning

The paper fills a genuine gap: linking UI policy to healthcare labor supply through Medicaid claims data. The literature review covers the key references (Coombs et al., Ganong et al., Autor and Duggan, Callaway and Sant'Anna).

### 5. Results Interpretation

Effect sizes are reasonable and well-calibrated. The 6.3% provider increase and 14.9% beneficiary increase are consistent with a labor supply response. The larger beneficiary effect is plausibly explained (supply-constrained markets).

### 6. Actionable Revision Requests

1. **Must-fix:** None. All code-to-table integrity issues have been resolved.
2. **High-value:** Discuss the TWFE vs CS-DiD RI divergence more explicitly (1-2 sentences explaining heterogeneous treatment effects).
3. **Optional:** Consider mentioning whether the effect persists or fades after the federal expiration date (September 2021), when all states converged.

## PART 2: CONSTRUCTIVE SUGGESTIONS

The paper is well-executed and clearly written. The main contribution (UI→HCBS provider supply) is novel and policy-relevant. The behavioral health placebo is the standout identification feature. No major structural changes needed.

## OVERALL ASSESSMENT

- **Key strengths:** Novel question, clean identification, comprehensive robustness, compelling placebo
- **Critical weaknesses:** None that would prevent publication
- **Publishability:** Ready after minor edits

DECISION: CONDITIONALLY ACCEPT
